Medical device startup Advanced Chemotherapy Technologies (ACT) just got another financial boost in its efforts to develop a targeted drug delivery system to attack pancreatic cancer.
Read More
The grant, in combination with prior financing, supports development of Advanced Chemotherapy’s local drug delivery system for the treatment of locally advanced non-resectable and borderline resectable pancreatic cancer.
Read More
Advanced Chemotherapy Technologies (ACT), a medical device startup developing a way to improve the treatment of pancreatic cancer, has added $2.5 million in funding to support clinical testing of its technology. Here’s the back story of the company’s development.
Read More
Advanced Chemotherapy Technologies, a Raleigh startyp focused on new means of targeting drug delivery to fight diseases such as pancreative cancer, has landed another $2.5 million in venture capital.
Read More
Advanced Chemotherapy Technologies (ACT) of Raleigh hopes to change the dim calculus for cancer patients.
Read More
Two North Carolina medical technology companies are among the six chosen to pitch their wares on April 9 during the inaugural Southeast Region Pitch Event.
Read More
